Guidelines for monitoring heparin by the activated clotting time when aprotinin is used during cardiopulmonary bypass

J Thorac Cardiovasc Surg. 1992 Jul;104(1):211-2.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Aprotinin / pharmacology*
  • Blood Coagulation / drug effects*
  • Cardiopulmonary Bypass*
  • Heparin / therapeutic use*
  • Humans
  • Whole Blood Coagulation Time*

Substances

  • Heparin
  • Aprotinin